TVTX vs PVLA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PVLA Captures Institutional Edge (3โ1 Pillars ยท 4โ6 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Palvella Therapeutics, Inc. Common Stock (PVLA) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while TVTX counters with relative strength in Valuation. Fundamentally, TVTX trades at 9.3x Forward P/E with -3.1% operating margin (+36.2% YoY revenue) versus PVLA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, TVTX sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro) against PVLA sits in CONSOLIDATION (2nd %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | TVTX Revenue | PVLA Revenue | TVTX Op. Margin | PVLA Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $160M | $30M | -48.7% | -113.1% | TVTX |
| FY2019 | $180M | $40M | -78.3% | -62.2% | PVLA |
| FY2020 | $200M | $30M | -88.8% | -115.7% | TVTX |
| FY2021 | $130M | $30M | -151.3% | -165.0% | TVTX |
| FY2022 | $110M | $30M | -292.2% | -167.8% | PVLA |
| FY2023 | $150M | $40M | -267.2% | -27.7% | PVLA |
| FY2024 | $230M | N/A | -138.9% | N/A | TVTX |
| FY2025 | $490M | N/A | -12.8% | N/A | TVTX |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | TVTX | PVLA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $4.9B | $2.2B | Larger Scale | TVTX |
| Trailing P/E Ratio Valuation | 25.8x | N/M | Lower Multiple | TVTX |
| Forward P/E Ratio Valuation | 9.3x | N/M | Lower Multiple | TVTX |
| Revenue Growth (YoY) Growth | +36.2% | +0.0% | Higher Growth | TVTX |
| Operating Margin (TTM) Profitability | -3.1% | 0.0% | Higher Margin | PVLA |
| Net Profit Margin Profitability | -18.7% | 0.0% | Higher Margin | PVLA |
| Return on Equity (ROE) Capital Efficiency | -321.2% | -63.4% | Higher ROE | PVLA |
| 52-Week Range Position Momentum | 59% ($23โ$69) | 68% ($72โ$180) | Stronger Trend | PVLA |
| Beta / 30D Volatility Risk Regime | 1.39ฮฒ ยท 44% Vol | 1.66ฮฒ ยท 75% Vol | Lower Realized Risk | TVTX |
| Unified Institutional Score Composite Signal | 60.2 / 100 (BUY) | 48.9 / 100 (HOLD) | Higher Composite | TVTX |